PuraMed BioScience engages in the research, development, and
marketing of non-prescription medicinal and healthcare products.
In addition to LipiGesic M, PuraMed BioScience plans to
launch LipiGesic H for tension-type headaches as well as LipiGesic
PM, which provides a remedy for insomnia and other sleep
disorders. For more information visit www.puramedbioscience.com
Marijuana Dispensaries Deal Could Spell End to Toxic Financing
Last Updated: Dec. 11, 2014 - 4:30pm EST
(NEW YORK)--PuraMed BioScience, Inc. (OTC:PMBS), a
developer of over-the-counter health and wellness products,
announced distribution funding deal that could spell higher prices
for their stock.
the distribution agreement, PMBS will gain access for their
MigraPure H migraine headache product to 1,000 marijuana
dispensaries, and other distribution venues throughout Colorado,
Washington State, and California.
End of Toxic Financing
The distribution deal to 1000 marijuana dispensaries is exciting
in itself, but what market should really make note of is that this
could spell the end of toxic financing for the company, and could
allow for higher share price.
For anyone that has followed PMBS the main issue with the Company
has been the issue of legacy convertible debt, which as many
small-cap traders know can become extremely dilutive for lower
Under this current distribution agreement though, PMBS is
receiving funding to launch product out to the 1000 dispensaries
under an exclusive rights agreement for a cut of the action, not
toxic convertible debt. This is a major development for PMBS as
this now removes the extreme overhang of aged debt, and reduces
prospects of sharp share dilution moving forward.
The Company may still have roughly $100,000 of older aged debt to
work through in the coming months with Magna Equities, but with
non-toxic funding in place, access to 1000 marijuana dispensaries,
product expected on shelves in early 2015, and only 215 million
outstanding, PMBS could provide some real value for traders as
stock current trades at a market cap of only $65,000.
Yes, you read that correct, market cap is only $65,000 at $0.0003
Safe Harbor Statements:
investor presentation may include statements that may constitute
forward-looking statements made pursuant to the safe harbor
provisions of the U.S. Private Securities Litigation Reform Act of
1995. Although the Company believes that the expectations
reflected in such forward-looking statements are based on
reasonable assumptions, such statements are subject to risks and
uncertainties that could cause actual results to differ materially
from those projected.
This is NOT a solicitation to Buy or Sell any security, but rather
is for informational purposes only. Content contained herein
includes facts, views, opinions and recommendations of individuals
and organizations deemed of interest. Wall Street Newscast
("WSNC") does not guarantee the accuracy, completeness
or timeliness of, or otherwise endorse these views, opinions or
recommendations, or give investment advice. WSNC, its affiliates,
or directors, may or may not hold a position in the above security
from time to time, and investors are encourage to consider this as
a possible conflict of interest when reviewing this information.
In Compliance with SEC Rule 17B Wall Street Newscast was
compensated two million restricted common shares for research and media
WSNC may hold a position in above securities from time to time,
and thus should be considered a possible conflict of interest when
reviewing this report and information. These investments may
involve a high degree of risk, thus investors are highly
encouraged to consult with a financial advisor before any and all